Immunocore Ranked No 1 South East Company in the Annual Sunday Times Hiscox Tech Track 100

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease, today notes that it has been ranked as the Number one company in the southeast region and number nine overall in the 15th annual Sunday Times Hiscox Tech Track 100.